IBDEI0YV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15555,1,3,0)
 ;;=3^Colonoscopy w/ Snare
 ;;^UTILITY(U,$J,358.3,15556,0)
 ;;=99341^^87^862^1
 ;;^UTILITY(U,$J,358.3,15556,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,15556,1,1,0)
 ;;=1^PROBLEM FOCUSED VISIT
 ;;^UTILITY(U,$J,358.3,15556,1,2,0)
 ;;=2^99341
 ;;^UTILITY(U,$J,358.3,15557,0)
 ;;=99342^^87^862^2
 ;;^UTILITY(U,$J,358.3,15557,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,15557,1,1,0)
 ;;=1^EXP PROBLEM FOCUSED VISIT
 ;;^UTILITY(U,$J,358.3,15557,1,2,0)
 ;;=2^99342
 ;;^UTILITY(U,$J,358.3,15558,0)
 ;;=99343^^87^862^3
 ;;^UTILITY(U,$J,358.3,15558,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,15558,1,1,0)
 ;;=1^DETAILED VISIT
 ;;^UTILITY(U,$J,358.3,15558,1,2,0)
 ;;=2^99343
 ;;^UTILITY(U,$J,358.3,15559,0)
 ;;=99344^^87^862^4
 ;;^UTILITY(U,$J,358.3,15559,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,15559,1,1,0)
 ;;=1^COMPREHENSIVE, MOD COMPLEX
 ;;^UTILITY(U,$J,358.3,15559,1,2,0)
 ;;=2^99344
 ;;^UTILITY(U,$J,358.3,15560,0)
 ;;=99345^^87^862^5
 ;;^UTILITY(U,$J,358.3,15560,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,15560,1,1,0)
 ;;=1^COMPREHENSIVE, HIGH COMPLEX
 ;;^UTILITY(U,$J,358.3,15560,1,2,0)
 ;;=2^99345
 ;;^UTILITY(U,$J,358.3,15561,0)
 ;;=99347^^87^863^1
 ;;^UTILITY(U,$J,358.3,15561,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,15561,1,1,0)
 ;;=1^PROBLEM FOCUSED VISIT
 ;;^UTILITY(U,$J,358.3,15561,1,2,0)
 ;;=2^99347
 ;;^UTILITY(U,$J,358.3,15562,0)
 ;;=99348^^87^863^2
 ;;^UTILITY(U,$J,358.3,15562,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,15562,1,1,0)
 ;;=1^EXPANDED PROBLEM FOCUSED 
 ;;^UTILITY(U,$J,358.3,15562,1,2,0)
 ;;=2^99348
 ;;^UTILITY(U,$J,358.3,15563,0)
 ;;=99349^^87^863^3
 ;;^UTILITY(U,$J,358.3,15563,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,15563,1,1,0)
 ;;=1^DETAILED VISIT
 ;;^UTILITY(U,$J,358.3,15563,1,2,0)
 ;;=2^99349
 ;;^UTILITY(U,$J,358.3,15564,0)
 ;;=99350^^87^863^4
 ;;^UTILITY(U,$J,358.3,15564,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,15564,1,1,0)
 ;;=1^COMPREHENSIVE VISIT
 ;;^UTILITY(U,$J,358.3,15564,1,2,0)
 ;;=2^99350
 ;;^UTILITY(U,$J,358.3,15565,0)
 ;;=B18.2^^88^864^38
 ;;^UTILITY(U,$J,358.3,15565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15565,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,15565,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,15565,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,15566,0)
 ;;=E11.9^^88^864^23
 ;;^UTILITY(U,$J,358.3,15566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15566,1,3,0)
 ;;=3^Diabetes Type 2
 ;;^UTILITY(U,$J,358.3,15566,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,15566,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,15567,0)
 ;;=E11.40^^88^864^21
 ;;^UTILITY(U,$J,358.3,15567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15567,1,3,0)
 ;;=3^DM Type 2 w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,15567,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,15567,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,15568,0)
 ;;=E78.2^^88^864^39
 ;;^UTILITY(U,$J,358.3,15568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15568,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,15568,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,15568,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,15569,0)
 ;;=E78.5^^88^864^40
 ;;^UTILITY(U,$J,358.3,15569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15569,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,15569,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,15569,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,15570,0)
 ;;=E66.3^^88^864^57
